Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.33T
Market cap1.33T
Price-Earnings ratio
46.39
Price-Earnings ratio46.39
Dividend yield
0.47%
Dividend yield0.47%
Average volume
3.65M
Average volume3.65M
High today
$1,424.00
High today$1,424.00
Low today
$1,400.00
Low today$1,400.00
Open price
$1,404.00
Open price$1,404.00
Volume
155.13K
Volume155.13K
52 Week high
$1,453.00
52 Week high$1,453.00
52 Week low
$850.51
52 Week low$850.51

Stock Snapshot

With a market cap of 1.33T, Eli Lilly(LLY) trades at $1,418.33. The stock has a price-to-earnings ratio of 46.39 and currently yields dividends of 0.47%.

During the trading session on 2026-11-10, Eli Lilly(LLY) shares reached a daily high of $1,424.00 and a low of $1,400.00. At a current price of $1,418.33, the stock is +1.3% higher than the low and still -0.4% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 155.13K, versus its average volume of 3.65M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,453.00 and a low of $850.51.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,453.00 and a low of $850.51.

LLY News

Benzinga 1h
FDA Flags Potential Vision Loss Risk With GLP-1 Drugs, Requiring Weight-Loss Medicines Like Wegovy and Ze - Benzinga

...

FDA Flags Potential Vision Loss Risk With GLP-1 Drugs, Requiring Weight-Loss Medicines Like Wegovy and Ze - Benzinga
Zacks 9h
Zacks Industry Outlook Highlights Eli Lilly, Novartis and Bayer

Chicago, IL – November 10, 2026 – Today, Zacks Equity Research discusses Eli Lilly (LLY Quick QuoteLLY - Free Report) , Novartis (NVS Quick QuoteNVS - Fr...

Zacks Industry Outlook Highlights Eli Lilly, Novartis and Bayer
Seeking Alpha 18h
Eli Lilly, Novo weight-loss drugs to get rare vision loss warning

Eli Lilly, Novo weight-loss drugs to get rare vision loss warning Nov 09, 2026, 3:28 PM ET Eli Lilly and Company (LLY) Stock, NVO Stock NOVO:CA By : Jonathan Bl...

Eli Lilly, Novo weight-loss drugs to get rare vision loss warning

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
9.1%
Sell
6.1%

More LLY News

24/7 Wall St. 19h
Hims & Hers Crashes 10% Ahead of Q3 Earnings Despite Major Eli Lilly Deal

Continue Reading Live: Will Hims & Hers Rebound After Tonight’s Q2 Earnings? Hims and Hers Health heads into Q2 earnings carrying a brutal Q1 miss, margin comp...

Hims & Hers Crashes 10% Ahead of Q3 Earnings Despite Major Eli Lilly Deal
TipRanks 20h
Eli Lilly’s Obesity Pill Found to Help with Sleep Apnea

U.S. pharmaceutical giant Eli Lilly (LLY) has announced that its obesity pill Foundayo has been found to significantly reduce the severity of sleep apnea. A lat...

Benzinga 22h
Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain?

Biotech ETFs face a pivotal week as Summit Therapeutics (NASDAQ:SMMT) approaches a key FDA decision, while fresh drug-development updates and Hims & Hers Health...

Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain?
TipRanks 23h
Eli Lilly Stock Rises After Canada Approves Public Reimbursement of Its Alzheimer’s Drug

Eli Lilly’s (LLY) stock is up 3% on Nov. 9 after Canada’s Drug Agency recommended that the cost of the company’s Kisunla (Donanemab) Alzheimer’s medication be r...

The Motley Fool 1d
Eli Lilly Is Now Worth Nearly 9 Novo Nordisks. Here's How the Gap Got So Wide.

Eli Lilly (LLY -0.79%) and Novo Nordisk (NVO +0.03%) both participate in one of the biggest pharma growth markets today, and that's the weight loss drug market....

Eli Lilly Is Now Worth Nearly 9 Novo Nordisks. Here's How the Gap Got So Wide.
The Motley Fool 3d
Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity Trials

Eli Lilly (LLY -0.79%) is much loved on Wall Street because of its highly successful GLP-1 weight-loss business. Novo Nordisk (NVO +0.03%) is much less apprecia...

Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity Trials
Simply Wall St 3d
Hims Partnership Could Be A Big Deal For Eli Lilly

Eli Lilly and Hims & Hers Health announced a partnership in early November 2026 that lets eligible patients obtain Zepbound and Foundayo on the Hims & Hers tele...

Hims Partnership Could Be A Big Deal For Eli Lilly

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
Vertex Pharmaceuticals
Flowserve
Trane Technologies
Ecolab
Freeport-McMoRan
Colgate

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.